Clinical Trial Update: Safety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver Failure [Phase 1, Phase 2]

View source ↗

Summary

This is an update on a Phase 1/2 trial evaluating diverse mesenchymal stem cell transplantation for liver failure. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Liver Failure | Phase 1, Phase 2 | Status: UNKNOWN